Unitedhealth Group INC Form 4 insider transactions

Frederick William McNabb III, a Director at UnitedHealth Group, acquired 388 deferred stock units as part of his quarterly compensation.

Charles D. Baker, a Director at UnitedHealth Group, acquired 343 deferred stock units on April 1, 2026, as part of his regular quarterly compensation.

Director Kristen Gil acquired deferred stock units as compensation for services rendered to UnitedHealth Group.

John H. Noseworthy, a Director at UnitedHealth Group, acquired 320 deferred stock units on April 1, 2026, as part of his regular quarterly compensation.

Paul R. Garcia, a Director at UnitedHealth Group, reported transactions involving the acquisition of common stock and deferred stock units.

Scott Gottlieb, a Director at UnitedHealth Group, acquired deferred stock units as part of his quarterly compensation.

Valerie Montgomery Rice, a Director at UnitedHealth Group, acquired 343 deferred stock units as part of her quarterly compensation.

UnitedHealth Group Director Timothy Patrick Flynn acquired 350 deferred stock units as part of his quarterly compensation.

UnitedHealth Group Director Valerie Montgomery Rice acquired 53 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group's CFO, Wayne S. DeVeydt, acquired 149.989 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's Chief Accounting Officer, Dennis Stankiewicz, acquired 68.058 shares of common stock as dividend equivalents on restricted stock units.

UnitedHealth Group Director Paul R. Garcia acquired 16 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director John H. Noseworthy acquired 52 shares of common stock as dividend equivalents on vested deferred stock units.

UnitedHealth Group's EVP & Chief Legal Officer, Christopher R. Zaetta, acquired 89.629 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's UHC CEO, Timothy J. Noel, acquired 102.329 shares as dividend equivalents on restricted stock units.

UnitedHealth Group Director Frederick William McNabb III acquired 64 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Timothy Patrick Flynn acquired 79 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group CEO Stephen J. Hemsley reported the acquisition of 61 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Charles D. Baker acquired 14 shares of common stock as dividend equivalents on vested deferred stock units.

UnitedHealth Group's EVP & Chief People Officer, Erin McSweeney, acquired 64.885 shares of common stock as dividend equivalents on restricted stock units.

UnitedHealth Group Director Michele J. Hooper acquired 292 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Kristen Gil acquired 8 shares of common stock as dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Scott Gottlieb reported the acquisition of one share of common stock through dividend equivalents on vested deferred stock units.

Patrick H. Conway, CEO of Optum, acquired 125.021 shares of UnitedHealth Group common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's UHC CEO Timothy Noel reported the acquisition of restricted stock units and non-qualified stock options, alongside a minor stock disposal for tax purposes.

UnitedHealth Group's Optum CEO, Patrick H. Conway, reported scheduled acquisitions of restricted stock units and non-qualified stock options, alongside a disposition for tax purposes.

UnitedHealth Group's Chief Accounting Officer, Thomas E. Roos, was granted restricted stock units and non-qualified stock options, alongside a disposition of shares for tax purposes.

UnitedHealth Group EVP & Chief Legal Officer Christopher R. Zaetta reported the vesting of restricted stock units and the grant of non-qualified stock options, along with a disposition of shares for tax purposes, as part of routine compensation.

UnitedHealth Group's EVP & Chief People Officer, Erin McSweeney, was granted restricted stock units and non-qualified stock options as part of her compensation plan.

UnitedHealth Group's CFO, Wayne S. DeVeydt, was granted 8,855 restricted stock units and 35,517 non-qualified stock options, vesting annually from 2027 to 2030.